<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-C
REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ
INTERDEALER QUOTATION SYSTEM
Filed pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934 and Rule 13a-17
or 15d-17 thereunder
CHOICE DRUG SYSTEMS, INC.
(Exact name of issuer as specified in charter)
2930 WASHINGTON BOULEVARD
BALTIMORE, MARYLAND 21230
(Address of principal executive offices)
(410) 646-7373
(Issuer's telephone number, including area code)
I. CHANGE IN NUMBER OF SHARES OUTSTANDING
Indicate any change (increase or decrease) of 5% or more in the
number of shares outstanding:
1. Title of Security: COMMON STOCK, $.01 PAR VALUE
2. Number of shares outstanding before the change: 9,823,810
3. Number of shares outstanding after the change: 13,323,810
4. Effective date of change: AUGUST 29, 1995
5. Method of change: ISSUANCE OF COMMON STOCK
Specify method (such as merger, acquisition, exchange, distribution,
stock split, reverse split, acquisition of stock for treasury, etc.): PRIVATE
PLACEMENT
Give brief description of transaction: PRIVATE PLACEMENT OF 3,500,000
SHARES OF COMMON STOCK
Date: September 7, 1995
CHOICE DRUG SYSTEMS, INC.
By: /s/ Don Thompson
-----------------------------
Name: Don H. Thompson
-----------------------------
Title: Chief Financial Officer
-----------------------------
